🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to learn about the study medicine CTB-AVP for ...
Status
Completed
Location
Pfizer Clinical Research Unit - Brussels
Start Date
2024-07-29
Trial ID
NCT06593054
Treatments Being Tested
A Phase 1, open-label, single-dose study to determine the safety and pharma...
Status
Completed
Location
University of Miami Clinical Pharmacology
Start Date
2024-11-10
Trial ID
NCT06157242
Treatments Being Tested
The purpose of this clinical trial is to learn about the pharmacokinetics, ...
Status
Completed
Location
Pfizer Clinical Research Unit - Brussels
Start Date
2022-10-07
Trial ID
NCT05554237
Treatments Being Tested
To assess the bioequivalence of Test oral formulation of FLURBIPROFEN 100 m...
Status
Completed
Location
Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit
Start Date
2012-12
Trial ID
NCT01910090
Treatments Being Tested
This is an open label, two period (fasted and fed), crossover study in up t...
Status
Completed
Location
ICON Plc.
Start Date
2022-09-13
Trial ID
NCT05527834
Treatments Being Tested
Based on the current literature, investigators hypothesize that patients wi...
Status
Terminated
Location
University of Louisville
Start Date
2014-03-06
Trial ID
NCT02099240
Treatments Being Tested
This is a Phase 1, open-label, three-part, study in approximately 96 health...
Status
Recruiting
Location
ICON, Clinical Research Phase I Unit
Start Date
2025-01-07
Trial ID
NCT06733675
Purpose: To investigate the effects of subliminal micropulse yellow laser a...
Status
Completed
Location
Ankara University Biotechnology Institute
Start Date
2018-01-01
Trial ID
NCT04234438
Most teams use a left double-lumen tube. The double-lumen tube is available...
Status
Completed
Location
Service d'Anesthésie, Hôpital Foch
Start Date
2009-08
Trial ID
NCT00969683
Treatments Being Tested
Introduction Retinitis pigmentosa (RP) is the most common form of genetic r...
Status
Enrolling By Invitation
Location
First Department of Ophthalmology, Pomeranian Medical University
Start Date
2024-09-01
Trial ID
NCT07088705
Treatments Being Tested